Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity

Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity

US Patent 5833976 · Granted Nov 10, 1998

Estimated economic value: $226,634,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for achieving therapeutically effective doses of anti-CD47 agents2025
Methods for treating myeloma by achieving therapeutically effective doses of ant2025
Ex vivo antibody production2024
Therapeutic anti-CD9 antibody2024
Means and methods for counteracting myeloproliferative or lymphoproliferative di2023
Methods for treating cancer by achieving therapeutically effective doses of anti2023
AML antigens and uses thereof2022
Methods for treating cancer by achieving therapeutically effective doses of anti2022
Methods for treating cancer by achieving therapeutically effective doses of anti2021
Therapeutic anti-CD9 antibody2021
Compositions for achieving therapeutically effective doses of anti-CD47 agents2021
Means and methods for influencing the stability of cells2020